So, Belzutifan is this thing called a HIF-2α pseudo-inhibitor. It’s used for VHL-associated RCC. And it’s mainly used to cut down on that tumor hypoxia signaling.
You can get it in 40 mg tablets. They suggest taking 120 mg every day. Each bottle has 90 tablets in it.
